MARSHALL WACE, LLP - IMMUNOPRECISE ANTIBODIES LTD ownership

IMMUNOPRECISE ANTIBODIES LTD's ticker is IPA and the CUSIP is 45257F200. A total of 26 filers reported holding IMMUNOPRECISE ANTIBODIES LTD in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of IMMUNOPRECISE ANTIBODIES LTD
ValueSharesWeighting
Q4 2021$447,000
-59.1%
83,384
-52.5%
0.00%
-80.0%
Q3 2021$1,092,000
+400.9%
175,514
+384.1%
0.01%
+400.0%
Q2 2021$218,000
-32.9%
36,259
+8.5%
0.00%0.0%
Q1 2021$325,00033,4230.00%
Other shareholders
IMMUNOPRECISE ANTIBODIES LTD shareholders Q2 2021
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 396,425$5,927,0000.29%
Gradient Capital Advisors, LLC 21,718$325,0000.18%
Hillsdale Investment Management Inc. 15,200$232,0000.02%
Orion Portfolio Solutions, LLC 15,821$237,0000.01%
IFP Advisors, Inc 1,960$30,0000.00%
BANK OF AMERICA CORP /DE/ 300$4,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
CITIGROUP INC 7$00.00%
MORGAN STANLEY 2,100$31,0000.00%
BANK OF MONTREAL /CAN/ 5,900$98,0000.00%
View complete list of IMMUNOPRECISE ANTIBODIES LTD shareholders